216 related articles for article (PubMed ID: 26216030)
1. Inflammasome activation in the liver: Focus on alcoholic and non-alcoholic steatohepatitis.
Szabo G; Iracheta-Vellve A
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S18-23. PubMed ID: 26216030
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.
Csak T; Ganz M; Pespisa J; Kodys K; Dolganiuc A; Szabo G
Hepatology; 2011 Jul; 54(1):133-44. PubMed ID: 21488066
[TBL] [Abstract][Full Text] [Related]
3. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice.
Iracheta-Vellve A; Petrasek J; Satishchandran A; Gyongyosi B; Saha B; Kodys K; Fitzgerald KA; Kurt-Jones EA; Szabo G
J Hepatol; 2015 Nov; 63(5):1147-55. PubMed ID: 26100496
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
[TBL] [Abstract][Full Text] [Related]
6. Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation.
Liu J; Wang T; He K; Xu M; Gong JP
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8158-8167. PubMed ID: 31599445
[TBL] [Abstract][Full Text] [Related]
7. Inflammasome activation and function in liver disease.
Szabo G; Petrasek J
Nat Rev Gastroenterol Hepatol; 2015 Jul; 12(7):387-400. PubMed ID: 26055245
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis.
Torres S; Segalés P; García-Ruiz C; Fernández-Checa JC
Cells; 2022 Apr; 11(9):. PubMed ID: 35563780
[TBL] [Abstract][Full Text] [Related]
9. The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis.
Knorr J; Wree A; Tacke F; Feldstein AE
Semin Liver Dis; 2020 Aug; 40(3):298-306. PubMed ID: 32526788
[TBL] [Abstract][Full Text] [Related]
10. Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis.
Csak T; Pillai A; Ganz M; Lippai D; Petrasek J; Park JK; Kodys K; Dolganiuc A; Kurt-Jones EA; Szabo G
Liver Int; 2014 Oct; 34(9):1402-13. PubMed ID: 24650018
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
[TBL] [Abstract][Full Text] [Related]
12. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.
Ganz M; Csak T; Szabo G
World J Gastroenterol; 2014 Jul; 20(26):8525-34. PubMed ID: 25024607
[TBL] [Abstract][Full Text] [Related]
13. The Emerging Relevance of AIM2 in Liver Disease.
Lozano-Ruiz B; González-Navajas JM
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906750
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
[TBL] [Abstract][Full Text] [Related]
15. Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome.
Yang G; Jang JH; Kim SW; Han SH; Ma KH; Jang JK; Kang HC; Cho YY; Lee HS; Lee JY
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316419
[TBL] [Abstract][Full Text] [Related]
16. [Role of NLRP3 inflammasome in the pathogenesis of alcoholic liver disease].
Bai X; Sun SS; Zhou JY
Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):567-571. PubMed ID: 31357788
[TBL] [Abstract][Full Text] [Related]
17. Progress in inflammasome activation and pyrolysis in alcoholic liver disease.
Wang S; Qing D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 45(8):999-1004. PubMed ID: 33053545
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis.
Gaul S; Leszczynska A; Alegre F; Kaufmann B; Johnson CD; Adams LA; Wree A; Damm G; Seehofer D; Calvente CJ; Povero D; Kisseleva T; Eguchi A; McGeough MD; Hoffman HM; Pelegrin P; Laufs U; Feldstein AE
J Hepatol; 2021 Jan; 74(1):156-167. PubMed ID: 32763266
[TBL] [Abstract][Full Text] [Related]
19. Differences in innate immune signaling between alcoholic and non-alcoholic steatohepatitis.
Petrasek J; Csak T; Ganz M; Szabo G
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1(0 1):93-8. PubMed ID: 23855302
[TBL] [Abstract][Full Text] [Related]
20. NLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver Inflammation.
Neumann K; Schiller B; Tiegs G
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
